Mangalam Drugs & Organics opened higher at ₹31.99, compared with its previous close of ₹31.79. During today's session, the stock has traded between ₹31.75 and ₹32.66, with an average traded price of ₹32.13. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Mangalam Drugs & Organics is now worth
₹ 2,213.00
resulting in a loss of
₹ 7,787.00 (77.87%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.26 (+0.82%)
Day High
₹32.66
Day Low
₹31.75
Day Open
₹31.99
Prev Close
₹31.79
Volume
16,833
Value Traded
₹0.05 Cr
1W Return
9.80%
1M Return
-12.10%
3M Return
15.50%
6M Return
2.27%
1Y Return
-54.02%
Market Cap (₹ Cr.)
51
PE Ratio
-1.30
PB Ratio
0.52
Dividend Yield
-
ROE
-43.08%
ROCE
-27.34%
Book Value (₹)
60.64
Face Value (₹)
10.00
EPS (TTM)
-4.83
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
9.80%
6 Week
-
1 Month
-12.10%
3 Month
15.50%
9 Month
-21.08%
Mangalam Drugs seeks shareholder nod for 78-year-old independent director
Mangalam Drugs and Organics seeks shareholder approval for appointing Prabhakar Raghunath Zavar as Independent Director. Zavar is 78 years old, requiring a special resolution under SEBI LODR Regulation 17(1A). Remote e-voting period runs from October 2, 2026 to October 31, 2026. Proposed term for the directorship is five consecutive years starting September 15, 2026.
12 days agoMangalam Drugs appoints S.N. Nanda & Co as statutory auditor for 5 years
Mangalam Drugs appoints S.N. Nanda & Co as statutory auditor for 5 years. L.N. Joshi & Co appointed as secretarial auditor until 58th AGM. V.S. Somani & Co retired after completing their audit term. Related party transaction resolution saw 17.64% dissent from non-promoters.
19 days agoMangalam Drugs & Organics defaults on ₹15.57 crore loans
Mangalam Drugs & Organics has defaulted on loans totalling ₹15.57 crore. The defaulted dues are owed to Bank of Maharashtra and Bank of Baroda. Repayments are overdue for more than 30 days across both lenders.
28 days agoMangalam Drugs schedules 53rd AGM for September 23, 2026
53rd AGM scheduled for September 23, 2026, via VC/OAVM. Remote e-voting opens September 19 and closes September 22. Shareholding cut-off date is September 16, 2026. B.M. Maheshwari appointed as Scrutinizer for the process.
1mo agoMangalam Drugs Q1 Results: Net loss narrows 45% YoY to ₹755 lakh
Mangalam Drugs & Organics reported a Q1FY26 standalone net loss of ₹755.36 lakh, significantly lower than the ₹1,372.80 lakh loss in Q1FY25. Revenue remained flat at ₹5,711.93 lakh. The Board appointed S.N. Nanda & Co. as statutory auditors and L.N. Joshi & Co. as secretarial auditors for five years.
2mo agoMangalam Drugs and Organics: Secretarial Auditor M/s. Ragini Chokshi & Co. Resigns Effective August 4, 2026
Mangalam Drugs and Organics Limited has disclosed the resignation of its Secretarial Auditor, M/s. Ragini Chokshi & Co., Practising Company Secretaries (FRN: 92897), effective August 4, 2026. The resignation was tendered by CS Abhishek Shukla, Partner of the firm, citing pre-occupancy with professional commitments and other unavoidable reasons. The intimation was filed on August 6, 2026, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and submitted to both BSE Ltd and the National Stock Exchange of India Limited.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Mangalam Drugs & Organics is now worth
₹ 2,213.00
resulting in a loss of
₹ 7,787.00 (77.87%)
Note: Past profits do not guarantee future returns.
